Voloridge Investment Management’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.27M | Buy |
374,850
+195,730
| +109% | +$2.23M | 0.02% | 792 |
|
|
2025
Q1 | $2.13M | Buy |
+179,120
| New | +$2.13M | 0.01% | 952 |
|
|
2024
Q4 | – | Sell |
-241,048
| Closed | -$5.42M | – | 1307 |
|
|
2024
Q3 | $5.42M | Sell |
241,048
-93,924
| -28% | -$2.11M | 0.02% | 758 |
|
|
2024
Q2 | $6.99M | Buy |
+334,972
| New | +$6.99M | 0.03% | 661 |
|
|
2022
Q4 | – | Sell |
-75,876
| Closed | -$989K | – | 1574 |
|
|
2022
Q3 | $989K | Buy |
+75,876
| New | +$989K | 0.01% | 1165 |
|
|
2021
Q3 | – | Sell |
-106,320
| Closed | -$2.82M | – | 1791 |
|
|
2021
Q2 | $2.82M | Buy |
106,320
+42,968
| +68% | +$1.14M | 0.02% | 861 |
|
|
2021
Q1 | $1.97M | Buy |
+63,352
| New | +$1.97M | 0.01% | 831 |
|